Advancing cancer therapy with custom-built alternating electric field devices
Abstract Background In glioblastoma (GBM) therapy research, tumour treating fields by the company Novocure™, have shown promise for increasing patient overall survival. When used with the chemotherapeutic agent temozolomide, they extend median survival by five months. However, there is a space to de...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Bioelectronic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42234-024-00164-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|